![]() |
Volumn 71, Issue 3, 2002, Pages 115-121
|
Changes in plasma protein binding have little clinical relevance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALFENTANIL;
AMITRIPTYLINE;
AUROTHIOMALATE;
BUPRENORPHINE;
BUTORPHANOL;
CARBAMAZEPINE;
CEFTRIAXONE;
CHLORPROMAZINE;
COCAINE;
DILTIAZEM;
DIPHENHYDRAMINE;
DOXORUBICIN;
ERYTHROMYCIN;
FENTANYL;
HALOPERIDOL;
IDARUBICIN;
ITRACONAZOLE;
LIDOCAINE;
METHYLPREDNISOLONE;
MIDAZOLAM;
MILRINONE;
NICARDIPINE;
PENTAMIDINE;
PROPOFOL;
PROPRANOLOL;
REMIFENTANIL;
SUFENTANIL;
UNINDEXED DRUG;
VERAPAMIL;
WARFARIN;
AREA UNDER THE CURVE;
DISTRIBUTION VOLUME;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG EXPOSURE;
DRUG HALF LIFE;
DRUG PROTEIN BINDING;
HUMAN;
NOTE;
PHARMACODYNAMICS;
PHARMACOLOGICAL PARAMETERS;
PLASMA PROTEIN BINDING;
PRIORITY JOURNAL;
THERAPEUTIC INDEX;
ANTICOAGULANTS;
AREA UNDER CURVE;
BLOOD PROTEINS;
DRUG INTERACTIONS;
HUMANS;
METABOLIC CLEARANCE RATE;
PHARMACOKINETICS;
WARFARIN;
|
EID: 0036218554
PISSN: 00099236
EISSN: None
Source Type: Journal
DOI: 10.1067/mcp.2002.121829 Document Type: Note |
Times cited : (694)
|
References (20)
|